QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA Approval NDA202100 (NEXTWAVE)
QUILLIVANT XR (METHYLPHENIDATE HYDROCHLORIDE) — FDA Approval NDA202100 (NEXTWAVE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: QUILLIVANT XR; Active ingredients: METHYLPHENIDATE HYDROCHLORIDE; Application number: NDA202100.
| Brand name | QUILLIVANT XR |
|---|---|
| Active ingredients | METHYLPHENIDATE HYDROCHLORIDE |
| Application number | NDA202100 |
| Sponsor | NEXTWAVE |
| Dosage form | FOR SUSPENSION, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20120927 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →